Ładuje się......
COVID-19 Susceptibility in Bronchial Asthma
BACKGROUND: Bronchial asthma has not been adequately assessed in coronavirus disease 2019 (COVID-19). Respiratory allergy is associated with significant reductions in the expression of angiotensin-converting enzyme 2 receptor, which is the entry receptor for COVID-19. OBJECTIVE: To observe COVID-19...
Zapisane w:
| Wydane w: | J Allergy Clin Immunol Pract |
|---|---|
| Główni autorzy: | , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American Academy of Allergy, Asthma & Immunology
2021
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7683297/ https://ncbi.nlm.nih.gov/pubmed/33242628 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaip.2020.11.020 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|